Epstein Secrets

rs.com/article/us-health-coronavirus-vaccines-modema/modema-files-for- u-s-vaccine-authorization-will-seek-eu-nod-idUSKEN28AIIU> (11/30, Steenhuysen, Erman) reports the FDA "said an advisory committee would meet to discuss the request on Dec. 17, making Modema's candidate the second highly effective va

etinintelligence.com/d2ad675465494372ad1731e4a850eaa8? pubid=fbi> (11/30, 6:35 p.m. ET, story 2, 6.21M), Lester Holt reported that Moderna President Stephen Hoge in an interview "told me he expects approval very soon." Hoge: "We're quite optimistic actually that the vaccine is — the data speaks for itself an

ess at a time when scientists are increasingly anxious about how the variants might slow or reverse progress made against the virus." Reuters (2/22, Erman), the Washington Post (2/22, Cunningham, Schemm, Shammas, Thebault, 10.52M), and the Wall Street Journal (2/22, Burton, Subscription Publication, 8

ity of COVID-19 Vaccines', held via Cisco Webex, with testimony from Pfizer Group President and Chief Business Officer John Young; Moderna President Stephen Hoge; Johnson & Johnson Janssen Pharmaceutical Companies Medical Affairs Vice President Richard Nettles; AstraZeneca BioPharmaceuticals Business Unit Pr

for Emergency Vaccine Approval.. @US_FDA MUST ACT QUICKLY!!! Operation Warp Speed has been a great modern day miracle." Reuters (11/30, Steenhuysen, Erman) reports the FDA "said an advisory committee would meet to discuss the request on Dec. 17, making Moderna's candidate the second highly effective v

ink it can really prevent severe disease." On NBC Nightly NewsVI (11/30, 6:35 p.m. ET, story 2, 6.21M), Lester Holt reported that Moderna President Stephen Hoge in an interview "told me he expects approval very soon." Hoge: "We're quite optimistic actually that the vaccine is - the data speaks for itself and

for Emergency Vaccine Approval.. @US_FDA MUST ACT QUICKLY!!! Operation Warp Speed has been a great modern day miracle." Reuters (11/30, Steenhuysen, Erman) reports the FDA "said an advisory committee would meet to discuss the request on Dec. 17, making Moderna's candidate the second highly effective v

hink it can really prevent severe disease." On NBC Nightly NewsVi (11/30, 6:35 p.m. Et story 2, 6.21M), Lester Holt reported that Moderna President Stephen Hoge in an interview "told me he expects approval very soon." Hoge: "We're quite optimistic actually that the vaccine is - the data speaks for itself and